American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome

Endocr Pract. 2005 Mar-Apr;11(2):126-34. doi: 10.4158/EP.11.2.125.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology
  • Diabetes Mellitus, Type 2 / etiology
  • Endocrinology*
  • Endothelium, Vascular / physiopathology
  • Female
  • Humans
  • Insulin Resistance
  • Metabolic Diseases / etiology*
  • Metabolic Diseases / metabolism
  • Metabolic Diseases / physiopathology
  • Polycystic Ovary Syndrome / complications*
  • Polycystic Ovary Syndrome / metabolism
  • Polycystic Ovary Syndrome / physiopathology
  • Societies, Medical
  • United States